HOME >> BIOLOGY >> NEWS
Abnormal chromosomes forecast leukemia relapse

COLUMBUS, Ohio Patients with acute myeloid leukemia (AML) who enter remission with abnormal chromosomes in bone marrow cells are twice as vulnerable to recurrence of their disease as are AML patients with normal bone marrow cells at remission, according to a new study.

The findings by researchers at The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute call for routine testing for chromosomal abnormalities in AML patients at diagnosis and again when patients enter remission.

If verified, the findings mean that AML patients showing chromosomal abnormalities early during remission should be considered for more intensive treatment, such as a bone marrow transplant, in an attempt to prevent a return of the disease. Patients with normal-looking chromosomes can receive standard therapy.

The findings are published in the June 15 issue of the Journal of Clinical Oncology.

"For the first time, we have shown in a relatively large group of patients that someone with AML who has abnormal chromosomes early during remission will relapse, even if blood counts and other parameters are favorable," says first author Guido Marcucci, associate professor of internal medicine and a hematologist/oncologist with OSU's James Cancer Hospital.

Since 1990, physicians have said that AML patients were in complete remission following treatment if their blood count was normal, and their bone marrow contained fewer than 5 percent of immature cells known as blasts.

By that definition, 60 percent to 70 percent of AML patients achieve complete remission, but only 30 percent to 40 percent of those patients remain in remission long enough to be considered completely cured of their disease.

"Achieving complete remission is an important step for a successful treatment," Marcucci says, "but it does not predict who will do well in the long run and who will relapse. We need
'"/>

Contact: Darrell E. Ward
Ward-15@medctr.osu.edu
614-293-3737
Ohio State University
16-Jun-2004


Page: 1 2

Related biology news :

1. Abnormally high number of Lou Gehrigs disease cases identified among Gulf War veterans
2. Abnormal plant shows scientists path to plant, animal development
3. Abnormal immune response may play major role in glaucoma, study says
4. Abnormalities in cellular anchoring protein cause fatal heart syndrome
5. Abnormal chemical bonds cause bleeding disorder
6. Abnormalities in stress hormone response among alcoholics
7. Researchers Find Protein Abnormality Associated With Alzheimers Disease
8. Scientists Show That Normal-looking Cells In Cervical Cancer May Be Abnormal
9. Multi-Center Study Provides Guidelines For Genetic Testing In Women With Breast Cancer: BRCA Abnormalities Multiply Risk Of Ovarian Cancer
10. UB Fertility Researchers Find They Can Predict Pregnancy By Assessing Two Sperm Abnormalities
11. COGA Suggests Genetic Loci For P3 Brain Wave Abnormality

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/13/2018)... ... November 13, 2018 , ... Kenall has enhanced the popular MedMaster MAEC Series ... redesigned linear overbed luminaires are equipped with symmetric ambient and asymmetric exam modes, and ... , Intended to be specified in pairs, the MAEC is 8” x 48” and ...
(Date:11/7/2018)... ... November 07, 2018 , ... Features such ... adjust to last-minute changes all contribute to client retention and referral business in ... travel and expense services provider says 80 percent of its new business is ...
(Date:11/6/2018)... (PRWEB) , ... November 06, 2018 , ... uBiome, the ... Biochemistry and Biophysics at the University of California, San Francisco (UCSF) and Co-President of ... a scientific adviser to uBiome since 2013, and we are honored that he is ...
Breaking Biology News(10 mins):
(Date:11/5/2018)... ... November 05, 2018 , ... ... 2Blades’ Transcription Activator Like (TAL) effector code technology for applications in advancing research ... the technology in plants. Since its discovery in 2009, the efficacy of TAL effector-based ...
(Date:10/31/2018)... ... 2018 , ... Myoscience, Inc. announced today that it has ... Tennessee. This study enrolled 125 patients and compares the effect of cryoanalgesia ... total knee replacement surgery (TKA). , The Myoscience iovera° system is currently being ...
(Date:10/29/2018)... (PRWEB) , ... October 29, 2018 , ... PracticeMatch ... employers nationwide, released its schedule of physician career fairs planned for 2019. The company ... will focus hosting live events in the areas of the country which have the ...
(Date:10/24/2018)... , ... October 22, 2018 , ... ... research scientists, clinicians, and medical experts from around the world, will host its ... will focus on best practices in testing, chromatography, centrifugation, as well as developments ...
Breaking Biology Technology:
Cached News: